Global GMP comparison

Global Supplement GMP Comparison: 21 CFR 111, Canada NHP GMP, TGA GMP, PIC/S — What's the Difference?

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Side-by-side comparison of supplement GMP requirements under US, Canada, Australia, and PIC/S frameworks to help factories identify overlaps and differences in quality control, batch records, release, and complaint handling.

Key answer

The four GMP frameworks overlap significantly in core principles (quality unit independence, batch record traceability, deviation and complaint closure, supplier management) but differ in details. The biggest gap is not in the system documentation but in how audit evidence is presented — the same batch record may be viewed differently by an FDA auditor vs. a TGA auditor. Factories already certified to 21 CFR 111 or NSF/ANSI 455-2 should focus on supplementing gap items and adjusting evidence presentation, not rebuilding the system.

Item-by-item comparison across four frameworks

Quality Control: All four frameworks require an independent quality unit. TGA and Canada NHP GMP have more explicit requirements for Qualified Person (QP/QA) qualifications and responsibilities. Batch Records: 21 CFR 111 has the most detailed distinction between Master Manufacturing Records (MMR) and Batch Production Records (BPR). Release: PIC/S and TGA emphasize formal QP release processes. Complaints & Recalls: Canada NHP GMP has more specific requirements for mock recall frequency and records. Supplier Management: All four frameworks are broadly consistent — supplier approval, COA verification, and periodic review are required.

  • 21 CFR Part 111: US dietary supplement cGMP, most widely referenced
  • Canada NHP GMP: Part 3, Natural Health Products Regulations
  • Australia TGA GMP: based on PIC/S Guide PE 009
  • PIC/S GMP Guide: multi-country mutual recognition framework, medicinal product baseline

FAQ

If I have a 21 CFR 111 audit report, can I use it directly for Canada NPN site licensing?+

Not a direct substitute, but it serves as strong supporting evidence. Health Canada generally accepts equivalent GMP audit reports but requires supplementary evidence for Canada-specific items — such as QA person qualifications, mock recall records, and French labeling controls where applicable.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.